Press release

Sequence Bio welcomes Joy Buckle as Vice President of Policy and Planning

September 5, 2019 | St. John's, Newfoundland & Labrador

sequence bio welcomes joy buckle as vice president of policy and planning

Sequence Bio, a Newfoundland and Labrador biotechnology company, is pleased to announce the addition of Joy Buckle to its leadership team as Vice President of Policy and Planning. In this new role, Joy will offer strategic direction to help expand the NL Genome Project throughout the province and drive stakeholder engagement to return benefits to communities and participants in Newfoundland and Labrador.

Joy brings almost 20 years’ experience in stakeholder engagement, policy development, and leadership to Sequence Bio. Prior to joining Sequence Bio, Joy worked to advance the interests of the province in various leadership roles for the Office of the Premier of Newfoundland and Labrador, Dwight Ball - most recently as Senior Advisor for Social Policy and ATTIPA Coordinator. Joy holds an MBA and an MSc focusing in Cancer Research from Memorial University, and spent 7 years in management at the telemedicine/teleconferencing division at the university’s Faculty of Medicine. 

Joy Buckle said today from St. John’s,I’m excited to join Sequence Bio to bring my past experience and business and science background to help advance the NL Genome Project. Sequence Bio is passionate about having a lasting, positive impact on the people of this province while driving economic growth, and I can’t wait to get started.

"Joy has spent her entire career working to make the province a better place and we are thrilled she is bringing this passion and strategic mindset to Sequence Bio,” Chris Gardner, CEO of Sequence Bio said. With the NL Genome Project enrolling participants in 8 clinics in Newfoundland and Labrador, Joy’s experience with building relationships and helping manage large projects will play an essential role as we continue to expand across the province.



About Sequence Bio

Sequence Bio is a local biotechnology company leading the NL Genome Project to research the one-of-a-kind genetic makeup of Newfoundland and Labrador and improve how we treat and prevent the diseases that impact us most. We are committed to putting Newfoundland and Labrador first by returning findings to participants and stakeholders to benefit the lives of individuals, families, and communities in the province for generations to come.

Learn more at SequenceBio.com and NLGenomeProject.ca

For additional information please contact

Sophie Harrington
VP, Marketing & Strategy
sophie@sequencebio.com